Show simple item record

dc.contributor.authorRabinovitz, Isaac
dc.contributor.authorMercurio, Arthur M.
dc.date2022-08-11T08:08:01.000
dc.date.accessioned2022-08-23T15:39:40Z
dc.date.available2022-08-23T15:39:40Z
dc.date.issued1996-01-01
dc.date.submitted2010-11-07
dc.identifier.citation<p>Biochem Cell Biol. 1996;74(6):811-21.</p>
dc.identifier.issn0829-8211 (Linking)
dc.identifier.doi10.1139/o96-087
dc.identifier.pmid9164650
dc.identifier.urihttp://hdl.handle.net/20.500.14038/26226
dc.description.abstractThe integrin family of adhesion receptors plays a major role in epithelial organization and function. Moreover, the altered expression and function of specific integrins most likely contributes significantly to carcinoma progression. The integrin alpha 6 beta 4, the focus of this review, is a receptor for several members of the laminin family and is preferentially expressed at the basal surface of most epithelia, where it contributes to basement membrane interactions. Mounting evidence suggests that the alpha 6 beta 4 integrin plays a key role in carcinoma cell biology. Several histopathological studies have established a correlation between alpha 6 beta 4 integrin expression and tumor progression. The importance of alpha 6 beta 4 expression in tumors in underscored by the findings that invading fronts of several carcinomas are enriched in the expression of alpha 6 beta 4 integrin ligands, such as laminin-1 and laminin-5. The participation of the alpha 6 beta 4 integrin in invasion is supported further by in vitro functional studies using carcinoma cells that have been transfected with the beta 4 cDNA. The mechanisms by which alpha 6 beta 4 contributes to tumor progression are probably related to its mechanical and signaling properties and are currently under intense study.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=9164650&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1139/o96-087
dc.subjectAntigens, Surface
dc.subjectApoptosis
dc.subjectBasement Membrane
dc.subjectHumans
dc.subjectIntegrin alpha6beta4
dc.subjectIntegrins
dc.subjectLaminin
dc.subjectNeoplasm Invasiveness
dc.subjectNeoplasm Metastasis
dc.subject*Neoplasms
dc.subjectReceptors, Laminin
dc.subjectSignal Transduction
dc.subjectAmino Acids, Peptides, and Proteins
dc.subjectCancer Biology
dc.subjectNeoplasms
dc.titleThe integrin alpha 6 beta 4 and the biology of carcinoma
dc.typeJournal Article
dc.source.journaltitleBiochemistry and cell biology = Biochimie et biologie cellulaire
dc.source.volume74
dc.source.issue6
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cancerbiology_pp/140
dc.identifier.contextkey1633365
html.description.abstract<p>The integrin family of adhesion receptors plays a major role in epithelial organization and function. Moreover, the altered expression and function of specific integrins most likely contributes significantly to carcinoma progression. The integrin alpha 6 beta 4, the focus of this review, is a receptor for several members of the laminin family and is preferentially expressed at the basal surface of most epithelia, where it contributes to basement membrane interactions. Mounting evidence suggests that the alpha 6 beta 4 integrin plays a key role in carcinoma cell biology. Several histopathological studies have established a correlation between alpha 6 beta 4 integrin expression and tumor progression. The importance of alpha 6 beta 4 expression in tumors in underscored by the findings that invading fronts of several carcinomas are enriched in the expression of alpha 6 beta 4 integrin ligands, such as laminin-1 and laminin-5. The participation of the alpha 6 beta 4 integrin in invasion is supported further by in vitro functional studies using carcinoma cells that have been transfected with the beta 4 cDNA. The mechanisms by which alpha 6 beta 4 contributes to tumor progression are probably related to its mechanical and signaling properties and are currently under intense study.</p>
dc.identifier.submissionpathcancerbiology_pp/140
dc.contributor.departmentDepartment of Cancer Biology
dc.source.pages811-21


This item appears in the following Collection(s)

Show simple item record